about
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study.Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cellsInhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma.A case of advanced intrahepatic cholangiocarcinoma accidentally, but successfully, treated with capecitabine plus oxaliplatin (CAPOX) therapy combined with bevacizumab: a case reportEfficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted therapy for biliary tract cancer.
@en
Targeted therapy for biliary tract cancer.
@nl
type
label
Targeted therapy for biliary tract cancer.
@en
Targeted therapy for biliary tract cancer.
@nl
prefLabel
Targeted therapy for biliary tract cancer.
@en
Targeted therapy for biliary tract cancer.
@nl
P2860
P356
P1433
P1476
Targeted therapy for biliary tract cancer.
@en
P2093
Junji Furuse
Takuji Okusaka
P2860
P304
P356
10.3390/CANCERS3022243
P577
2011-05-03T00:00:00Z